FDA Drug Shortage Database
Rifampin (Rifadin) shortage
The FDA Drug Shortage Database lists 7 of 13 rifampin presentations as limited or unavailable (updated October 6, 2026); the first entry was posted on February 17, 2021. 5 more presentations are on the list as available.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 150mg capsule | 1 | 2 | 0 |
| 300mg capsule | 3 | 3 | 0 |
| 600mg injection | 3 | 0 | 0 |
| 600mg/10ml injection | 0 | 0 | 1 |
Which presentations are listed?
Limited or unavailable now (7)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Rifadin, Injection, 600 mg (NDC 0068-0597-01) | Sanofi-Aventis U.S. LLC | Current posted February 17, 2021, updated September 18, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Rifampin, Capsule, 150 mg (NDC 42806-801-01) | Epic Pharma, LLC | Current posted December 22, 2021, updated October 5, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Rifampin, Capsule, 300 mg (NDC 42806-799-01) | Epic Pharma, LLC | Current posted December 22, 2021, updated October 5, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Rifampin, Capsule, 300 mg (NDC 42806-799-05) | Epic Pharma, LLC | Current posted December 22, 2021, updated October 5, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Rifampin, Capsule, 300 mg (NDC 42806-799-30) | Epic Pharma, LLC | Current posted December 22, 2021, updated October 5, 2026 | Unavailable; Discontinuation of the manufacture of the drug |
| Rifampin, Injection, 600 mg (NDC 63323-351-20) | Fresenius Kabi USA, LLC | Current posted February 17, 2021, updated October 6, 2026 | Limited Availability; Other |
| Rifampin, Injection, 600 mg (NDC 67457-445-60) | Mylan Institutional, a Viatris Company | Current posted February 17, 2021, updated October 5, 2026 | Unavailable; Demand increase for the drug |
Listed now, available (5)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Rifampin, Capsule, 150 mg (NDC 42806-801-30) | Epic Pharma, LLC | Current posted December 22, 2021, updated October 5, 2026 | Available |
| Rifampin, Capsule, 150 mg (NDC 68180-658-06) | Lupin Pharmaceuticals, Inc. | Current posted December 22, 2021, updated September 1, 2026 | Available |
| Rifampin, Capsule, 300 mg (NDC 42806-799-60) | Epic Pharma, LLC | Current posted December 22, 2021, updated October 5, 2026 | Available |
| Rifampin, Capsule, 300 mg (NDC 68180-659-06) | Lupin Pharmaceuticals, Inc. | Current posted December 22, 2021, updated September 1, 2026 | Available |
| Rifampin, Capsule, 300 mg (NDC 68180-659-07) | Lupin Pharmaceuticals, Inc. | Current posted December 22, 2021, updated September 1, 2026 | Available |
Resolved or discontinued (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01) | Sanofi-Aventis U.S. LLC | To Be Discontinued posted April 20, 2026, updated April 20, 2026 | not given |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage